JOURNAL OF CLINICAL SURGERY ›› 2023, Vol. 31 ›› Issue (10): 949-953.doi: 10.3969/j.issn.1005-6483.2023.10.014

Previous Articles     Next Articles

Correlation of BRD4 expression level in colorectal cancer tissue with clinicopathological characteristics and prognosis of patients

  

  1. Department of General Surgery,the Third Medical Center of PLA General Hospital,Beijing 100039,China
  • Received:2022-11-18 Accepted:2022-11-18 Online:2023-10-20 Published:2023-10-20

PDF (PC)

287

Abstract: Objective   To analyze the expression of bromodomaincontaining protein 4 (BRD4) in colorectal cancer (CRC) tissue,and to explore its relationship with clinicopathological characteristics and prognosis of patients.  Methods   CRC patients admitted to our hospital from November 2014 to May 2017 were collected,and CRC tissue and paracancerous tissue were excised from the patients during radical resection.Real-time fluorescence quantitative PCR (qRT-PCR) and immunohistochemistry were used to measure the expression of BRD4 mRNA and BRD4 protein in CRC tissue and paracancerous tissue,respectively;Kaplan-Meier survival curve was used to analyze the relationship between BRD4 expression and patient prognosis;COX regression was applied to analyze the risk factors affecting the prognosis of CRC patients.  Results   Compared with the adjacent tissues,the expression level of BRD4 mRNA and the positive expression rate of BRD4 protein in CRC tissues were obviously increased (P<0.05).The expression level of BRD4 mRNA was correlated with regional lymph node metastasis (N) and distant metastasis (M) in CRC patients (P<0.05),the expression of BRD4 protein was correlated with the degree of tissue differentiation,N and M in CRC patients (P<0.05).Kaplan-Meier analysis showed that the 5-year progression-free survival rates of patients with high BRD4 mRNA expression and BRD4 protein positive expression were obviously lower than those of patients with low BRD4 mRNA expression (P＜0.05) and BRD4 protein negative expression (P＜0.05).The 5-year cumulative survival rates of patients with high expression of BRD4 mRNA and positive expression of BRD4 protein were significantly lower than those with low expression of BRD4 mRNA (P＜0.05) and negative expression of BRD4 protein (24/32) (P＜0.05) patients.Multivariate COX regression analysis showed that N1-N2,M1,the high expression of BRD4 mRNA and the positive expression of BRD4 were risk factors affecting the prognosis of CRC patients (P<0.05).  Conclusion   BRD4 is highly expressed in CRC tissue,there is a certain correlation with N,M and prognosis of patients,and it can be used as one of the indicators for the prognosis of CRC patients.

Key words: colorectal cancer, bromodomain-containing protein 4, clinicopathological features, prognosis

[1] YAN Xiaokun, WU Qinghua, CHEN Shaomu, CHENG Zewen. Predictive value of postoperative drainage volume and lung function for pulmonary complications after thoracoscopic lobectomy in patients with non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(9): 848-851.
[2] WANG Qingfeng, LU Jingjing, LU Shenglin, WANG Yuan, WU Yongfeng, ZHANG Mingfu. Analysis of related influencing factors and prognosis of complications of laparoscopic radical gastrectomy after neoadjuvant chemotherapy [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(9): 860-863.
[3] Ailijiang· Duolikun, Aizizi· Abulaiti, CHEN Kang. Expression levels and clinical significance of plasma lncRNA ANRIL and miR-191 in patients with non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 729-732.
[4] CHEN Jixin, LIAO Peng, ZHOU Yuhuai, Liu Tianyun. CircHERC4 inhibits the proliferation,migration and invasion of colorectal cancer cells by regulating the miR-105-5p/Skp2 axis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 733-737.
[5] SUN Fei, ZHOU Jiaquan, WANG Fei. Increased tissue POLR3G expression predicts adjuvant chemotherapy response and poor prognosis in muscular invasive bladder cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 763-767.
[6] LIANG Linhu, ZHANG Zhengrong, LI Haoran, CHENG Zhengwu, JIANG Houxiang. Neurotropic invasion in patients with colorectal cancer resection and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(8): 773-777.
[7] WU Haiyan, SHAO Zesheng, CUI Hengfeng. Prediction of serum albumin and alkaline phosphatase levels in patients with colorectal cancer on lymph node metastasis after laparoscopic radical surgery [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(7): 654-658.
[8] ZHANG Jiayuan, XIAO Changfang, YAO Yibo. Clinical value of simplified Fournier’s gangrene severity index in predicting the prognosis of perianal necrotizing fasciitis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(6): 524-527.
[9] ZHAO Feilong, WU Wenya, TIAN Jun, et al. Analysis of the superiority and safety of natural orifice specimen extraction surgery compared with traditional laparoscopic surgery in colorectal cancer [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(6): 538-541.
[10] LIU Wanzhong, LONG Xuan, DENG Zhigang. Relationship between transcription factor E2F2 and mucinlike receptor 2 levels in colorectal cancer and clinicopathological features and their diagnostic value for lymph node metastasis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(6): 542-545.
[11] XU Yu, MA Yixuan, ZHAO Kai, et al. Comparison of clinical features and surgical outcomes in trigeminal neuralgia caused by arterial/venous compression:a single-center follow-up analysis of 335 cases [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(5): 423-427.
[12] LIU Jinwei, BA Linchao, ZHANG Jingfu, et al. Expression of hypoxia-induced lipid droplet-associated protein in hepatocellular carcinoma and clinical significance [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(5): 447-452.
[13] XU Hui, LI Hao, QIN Jingjing, et al. The value of preoperative plasma fibrinogen as a prognostic index in patients with non metastatic gastric cancer:a Meta-analysis [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(4): 348-352.
[14] JI Shengwei, WANG Ping. Multivariate Logistic analysis of metastatic colorectal cancer combined with digestive tract perforation,construction and validation of the prediction model [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(3): 275-278.
[15] KONG Dejian, CHEN Jiabo, YANG Shi, et al. Correlation of posterior urethral dilatation with severity and prognosis of posterior urethral valvular disease [J]. JOURNAL OF CLINICAL SURGERY, 2023, 31(3): 279-282.
Viewed
Full text
287
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 287

  From Others local
  Times 6 281
  Rate 2% 98%

Abstract
174
Just accepted Online first Issue
0 0 174
  From Others
  Times 174
  Rate 100%

Cited
Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 828 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 847 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(5): 381 -0 .
[4] TAN Fengwei, XUE Qi, MOU Juwei, et al. nterpretation of surgical treatment of adenocarcinoma of the esophagus stomach from the latest guidelines[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(9): 641 -643 .
[5] . Heart transplantation with pulmonary hypertension[J]. JOURNAL OF CLINICAL SURGERY, 2018, 26(12): 896 -898 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(3): 203 -204 .
[7] . Clinical curative effect and the immune function influence of Mammotome minimally invasive surgery on 1 cm benign breast diseases[J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(3): 205 -208 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(5): 376 -378 .
[9] WANG Kui, CHEN Qinjunjie, XIA Yong, et al. Comprehensive treatment of surgical for intrahepatic cholangiocarcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(8): 638 -641 .
[10] ZHANG Wenchuan. Application of nerve electrophysiological monitoring technique in microvascular decompression, radiofrequency thermocoagulation and balloon compression for trigeminal neuralgia[J]. JOURNAL OF CLINICAL SURGERY, 2019, 27(10): 837 -839 .
Copyright © JOURNAL OF CLINICAL SURGERY, All Rights Reserved.
Tel: 027-87893476　E-mail: whlcwk@126.com
Powered by Beijing Magtech Co. Ltd